News on haematological malignancies
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…
Browsing: Haematology
Study of tagraxofusp reports 90 percent response rate for deadly blood cancer with no prior available therapies
An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD…
The Leukaemia Atlas: researchers unveil proteins that signal disease
Only about one in four people diagnosed with acute myelogenous leukaemia (AML) survive five years…
Vaccination against Epstein-Barr virus might reduce the risk of developing Hodgkin’s lymphoma, study suggests
Cells of certain blood cancers such as Hodgkin’s lymphoma carry the protein CD30 on their…
Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works
11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019, according to…
‘Nanobodies’ from alpacas could help bring CAR T-cell therapy to solid tumours
In 1989, two undergraduate students at the Free University of Brussels were asked to test…
Older adults with blood cancers: How they fare
Although the majority of patients who have blood cancers are older adults, they make up…
Mutation stands in the way of healthy blood cell maturation
In the veins, stem cells constantly mature and develop into different blood cells that are…
A step towards recovering reproduction in girls who survive childhood cancer
Leukaemia treatments often leave girls infertile, but a procedure developed by researchers at the University…
AACR 2019: Single agent umbralisib effective for relapsed slow-growing lymphoma
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…